U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. News & Events (Biologics)
  4. Workshops, Meetings & Conferences (Biologics)
  5. 2018 Center for Biologics Evaluation and Research Science Symposium Preliminary Agenda
  1. Workshops, Meetings & Conferences (Biologics)

2018 Center for Biologics Evaluation and Research Science Symposium Preliminary Agenda

Preliminary Agenda

June 25, 2018

Opening Remarks
RADM Denise Hinton
Acting Chief Scientist, FDA

Session 1: Emerging and Re-Emerging Infectious Diseases

Confirmed Speakers:

Anthony Fauci, MD
Director, National Institute of Allergy and Infectious Diseases, NIH

Hira Nakhasi, MSc, PhD
Division Director & Principal Investigator, Office of Blood Research & Review, CBER, FDA

Hong Yang, PhD
Principal Investigator, Office of Biostatistics and Epidemiology, CBER, FDA

Tod Merkel, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA

Session 2: Harnessing Diverse Types of Data in Regulatory Decision-making

Confirmed Speakers: 

David Madigan, PhD
Executive Vice President and Dean of Faculty of Arts and Sciences and Professor of Statistics, Columbia University

Steven Goodman, MD, MHS, PhD
Associate Dean & Professor, Stanford University

Taxiarchis Botsis, PhD
Investigator, Johns Hopkins University

Richard Forshee, PhD
Associate Director for Research, Office of Biostatistics and Epidemiology, CBER, FDA

Session 3: Immunogenicity and Immunotherapy

Confirmed Speakers:

John Tsang, PhD
Director, Computational Systems Biology, Trans-NIH Center for Human Immunology (CHI), NIAID, NIH

Carol Weiss, MD, PhD
Laboratory Chief & Principal Investigator, Office of Vaccines Research & Review, CBER, FDA

Zuben Sauna, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA

Raj Puri, MD, PhD
Division Director & Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA

June 26, 2018

Opening Remarks

Peter Marks, MD, PhD
Center Director, CBER, FDA

Session 4:  New Approaches to Improve Biologics and Treatments

Confirmed Speakers:

Aviv Regev, PhD
Chair of the Faculty & Director of the Klarman Cell Observatory and Cell Circuits Program, Co-Director of the Cell Atlas Project, Broad Institute

Chava Kimchi-Sarfaty, PhD
Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA

Arifa Khan, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA

CD Atreya, PhD
Associate Director for Research & Principal Investigator, Office of Blood Research & Review, CBER, FDA

Historical Speaker

Lawrence Bachorik, PhD
Former FDA Associate Commissioner for Communications

Session 5: Microbiome in Human Disease

Confirmed Speakers:

Vincent Young, MD, PhD
Professor, University of Michigan

Paul Carlson, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA

Vahan Simonyan, PhD
Lead Scientist, High-Performance Integrated Virtual Environment Project Director, CBER, FDA

Session 6: Advances in Regenerative Medicine

Confirmed Speakers:

Jordan Miller, PhD
Investigator, Rice University

Steven Bauer, PhD
Laboratory Chief & Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA

Malcolm Moos, MD, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA

Kyung Sung, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA

ResourcesForYou